1 May 2010 – Nordic Group obtained exclusive marketing rights for Mitomycin-C, an antineoplastic agent by Kyowa Hakko Kirin.

Mitomycin – „Golden” standard in the treatment of superficial carcinoma of the bladder after a transurethral resection (TUR).

Therapeutic protocols for bladder cancer:

  • Low risk tumours: 40 mg single instillation after transurethral resection (TUR) – “one shot”.
  • Medium and high risk tumours: “one shot” therapy + maintenance therapy – 6-8 weeks/once a week + 6-8 months/once a month
Drug availability

Availability on the Bulgarian market:

Mitomycin 20 mg x 1 vial

Mitomycin is a prescription medicine. Mitomycin is not reimbursed by the National Health Fund, it is prescribed by a doctor and can be bought from any Pharmacy in the whole country.

For more information you can address the specialists from the oncology network in the country as well as us.

Mitomycin can be freely purchased with a prescription from any pharmacy in the country after an order to the drug distributors Novus Trading, Medex or Phoenix.

Maximum pharmacy price of Mitomycin

Mitomycin 20 mg x 1 vial – 64.82 BGN. incl. VAT

Mitomycin Distributor for Bulgaria

Novus Trading Plc
T: +359 2 8586039;
M: +359 87 7539010